profit from every $100 of sales.

Medtronic
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2026.
You pay $26.63 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Medtronic sold, what it kept, and what it did with the cash.
Sales went from $31.2 billion in 2023 to $36.4 billion in 2026, with $4.80 billion of profit last year.
Medtronic handed back 86% of the cash it generated last year.
Medtronic vs. similar companies
Medtronic grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Medtronic | 26.6× · Fair price | ||
Abbott Laboratories | 27.3× · Fair price | ||
Stryker | 36.4× · Expensive | ||
Edwards Lifesciences | 54.6× · Expensive | ||
Siemens Healthineers | 24.8× · Fair price |
Compare Medtronic with AbbVie · Amgen · Bristol-Myers Squibb · Intuitive Surgical · Johnson & Johnson · Eli Lilly · McKesson · Novo Nordisk
AI analysis
An AI analyst reads Medtronic's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 30,117 | 31,686 | 31,227 | 32,364 | 33,537 | 36,364 | |
| 19,634 | 21,541 | 20,508 | 21,148 | 21,905 | 23,643 | |
| – | 5,908 | 5,830 | 5,520 | 6,540 | – | |
| 7,522 | 8,777 | 8,697 | 8,203 | 9,218 | 9,809 | |
| 3,606 | 5,039 | 3,758 | 3,676 | 4,662 | 4,801 | |
| 2.66 | 3.73 | 2.82 | 2.76 | 3.61 | 3.73 | |
| 65.2% | 68.0% | 65.7% | 65.3% | 65.3% | 65.0% | |
| – | 18.6% | 18.7% | 17.1% | 19.5% | – | |
| 12.0% | 15.9% | 12.0% | 11.4% | 13.9% | 13.2% |
Balance sheet
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Total assets | 93,083 | 90,981 | 90,948 | 89,981 | 91,680 | 93,028 |
| Cash | 3,593 | 3,714 | 1,543 | 1,284 | 2,218 | 1,949 |
| Total debt | 26,389 | 24,114 | 24,364 | 25,024 | 28,516 | 27,961 |
| Total liabilities | 41,481 | 38,259 | 39,283 | 39,561 | 43,424 | 42,956 |
| 51,428 | 52,551 | 51,483 | 50,214 | 48,024 | 49,463 | |
| 1,354 | 1,351 | 1,333 | 1,330 | 1,290 | 1,288 | |
| 4.9% | 6.3% | 6.2% | 5.8% | 6.6% | 7.0% | |
| 7.0% | 9.6% | 7.3% | 7.3% | 9.7% | 9.7% |
Cash flow
| In millions of USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| 6,240 | 7,346 | 6,039 | 6,787 | 7,044 | 7,330 | |
| 1,355 | 1,368 | 1,459 | 1,587 | 1,859 | 1,904 | |
| 4,885 | 5,978 | 4,580 | 5,200 | 5,185 | 5,426 | |
| Dividends paid | 3,120 | 3,383 | 3,616 | 3,666 | 3,589 | 3,639 |
| 652 | 2,544 | 645 | 2,138 | 3,235 | 1,035 | |
| 344 | 359 | 355 | 393 | 429 | 457 |
Valuation
- 26.6×
- 16.5×
- 3.81
- 2.6×
- 3.5×
- 23.6×
- 15.7×
- 4.2%
- 3.8%
- 3.5%
Profitability
- 65.0%
- 18.8%
- 13.2%
- 25.0%
- 7.2%
- 6.6%
- 9.9%
- 5.2%
- 7.9%
- 7.9%
Growth
- +3.8%
- +7.0%
- +4.6%
- +4.4%
- −1.1%
Financial health
- 2.7×
- 0.57
- 30.7%
- 9.6×
- 2.13
- 2.62
- 0.40
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
What analysts expect
- Average price target
- $109.50
- Range
- $95.00 – $120.00
- 9 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 17, 2026 | 1.36 | 1.34 | +1.5% |
| Nov 18, 2025 | 1.36 | 1.31 | +3.8% |
| Aug 19, 2025 | 1.26 | 1.23 | +2.4% |
| May 21, 2025 | 1.62 | 1.58 | +2.5% |
| Feb 18, 2025 | 1.39 | 1.36 | +2.2% |
| Nov 19, 2024 | 1.26 | 1.25 | +0.8% |
| Aug 20, 2024 | 1.23 | 1.20 | +2.5% |
| May 23, 2024 | 1.46 | 1.45 | +0.7% |
Paid per share, each year
$1.45 in 2015 → $2.83 in 2025
How safe it looks
75.8% of its profit
Room to growStretchedMore than it earns: 67.1%
News
Medtronic Is About to Report Its First Earnings Since Spinning Off MiniMed. Should You Buy the Stock Before Nov. 24?Yahoo Finance · Nov 21, 2026Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?Yahoo Finance · Nov 1, 2026History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.Yahoo Finance · Oct 1, 2026Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?Yahoo Finance · Sep 27, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Medtronic
Is Medtronic a good stock to buy?
A solid business at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Medtronic AI analysis
What does Medtronic do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It is in Medical Devices, based in Galway, Ireland, with 95,000 employees.
Does Medtronic pay a dividend?
Yes. At today's price the dividend is 3.5% a year, about 76% of its yearly profit. In 2026 it paid out $3.64 billion in dividends.
Is Medtronic stock halal?
Yes. Medtronic passes our halal screen: its business is permitted and its debt is 22% of its market value, under the 30% limit. How we check
How has Medtronic stock done over the past year?
Up 0.6% over the past twelve months, to $99.94. It traded between $73.75 and $105.35 and is 5.1% below its high.
Who are Medtronic's competitors?
The largest listed companies in the same industry are Abbott Laboratories, Stryker, Edwards Lifesciences and Siemens Healthineers. The peers table on this page compares their profit, growth and price with Medtronic's.
Prices: daily closes to Nov 20, 2026. Fundamentals: company reports via invest-like data.



